Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced ...

(“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced the publication of ...

Gov. Gavin Newsom is open to giving California public employees a temporary break on his return-to-office mandate. The union representing about 14,000 state engineers announced a deal that would delay ...

Scientists with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States, and a leading research center for diabetes and other ...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 ...

T-Mobile US, Inc. (NASDAQ: TMUS ) looks forward to discussing second quarter 2025 financial and operational results on Wednesday, July 23, 2025, at 4:30 p.m. Eastern Daylight Time (EDT). The call will ...

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO) (OTCQB:ONNVF) (Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co ...

Southwest Airlines has added new runway and landing warning systems to nearly every aircraft in its fleet, as tragic disasters and troubling close calls shake the air travel industry. Developed ...

Georgia Power and Mitsubishi Power have successfully completed a second trial blending hydrogen and natural gas fuels at both partial and full load on an M501GAC natural gas turbine at Georgia ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that its Shield multi-cancer detection (MCD) test has been granted Breakthrough Device designation from ...

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting ...

SAN FRANCISCO--(BUSINESS WIRE)--May 21, 2025-- ...